Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Homo sapiens | MET proto-oncogene, receptor tyrosine kinase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Get druggable targets OG5_130320 | All targets in OG5_130320 | |
Onchocerca volvulus | Tyrosine kinase homolog | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Brugia malayi | Immunoglobulin I-set domain containing protein | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0011 | 0.0005 | 0.0002 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.0005 | 0.0005 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0008 | 0.0005 |
Onchocerca volvulus | 0.0021 | 0.0037 | 0.0639 | |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0017 | 0.0014 |
Echinococcus multilocularis | roundabout 2 | 0.0018 | 0.0027 | 0.0027 |
Echinococcus granulosus | twitchin | 0.0022 | 0.004 | 0.004 |
Brugia malayi | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0005 | 0.0005 |
Echinococcus multilocularis | twitchin | 0.0011 | 0.0003 | 0.0003 |
Onchocerca volvulus | 0.0167 | 0.0524 | 0.9695 | |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.3007 | 1 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0015 | 0.0017 | 0.0017 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.0005 | 0.0005 |
Plasmodium falciparum | protein kinase, putative | 0.001 | 0 | 0.5 |
Brugia malayi | Plexin repeat family protein | 0.0021 | 0.0037 | 0.0034 |
Schistosoma mansoni | nephrin | 0.0014 | 0.0015 | 0.0015 |
Trypanosoma brucei | protein kinase, putative | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0027 | 0.0024 |
Loa Loa (eye worm) | plexin A | 0.0025 | 0.005 | 0.0047 |
Schistosoma mansoni | titin | 0.0011 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0014 | 0.0015 | 0.0012 |
Schistosoma mansoni | vesicular amine transporter | 0.0011 | 0.0005 | 0.0005 |
Schistosoma mansoni | plexin | 0.0021 | 0.0037 | 0.0037 |
Leishmania major | protein kinase, putative | 0.001 | 0 | 0.5 |
Echinococcus granulosus | roundabout 2 | 0.0018 | 0.0027 | 0.0027 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0172 | 0.054 | 1 |
Echinococcus granulosus | plexin a4 | 0.0025 | 0.005 | 0.005 |
Trypanosoma brucei | STE/STE11 serine/threonine-protein kinase, putative | 0.001 | 0 | 0.5 |
Echinococcus granulosus | titin | 0.0011 | 0.0003 | 0.0003 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.001 | 0 | 0.5 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.0005 | 0.0005 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | titin | 0.0011 | 0.0003 | 0.0003 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.0005 | 0.0005 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0184 | 0.058 | 0.0578 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.0005 | 0.0005 |
Echinococcus granulosus | titin | 0.0011 | 0.0003 | 0.0003 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0011 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0037 | 0.0034 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0184 | 0.058 | 0.0578 |
Toxoplasma gondii | calcium dependent protein kinase CDPK8 | 0.001 | 0 | 0.5 |
Brugia malayi | plexin A | 0.0025 | 0.005 | 0.0047 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0005 | 0.0005 |
Schistosoma mansoni | serine/threonine protein kinase | 0.3007 | 1 | 1 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.3007 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0027 | 0.0024 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0017 | 0.0017 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0005 | 0.0002 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0015 | 0.0015 |
Entamoeba histolytica | protein kinase domain containing protein | 0.001 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0008 | 0.0008 |
Echinococcus multilocularis | plexin a4 | 0.0025 | 0.005 | 0.005 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0011 | 0.0003 | 0.0003 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0011 | 0.0005 | 0.0002 |
Schistosoma mansoni | plexin | 0.0012 | 0.0008 | 0.0008 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.3007 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 8.85 uM | Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay | ChEMBL. | 25082515 |
IC50 (binding) | > 10 uM | Inhibition of human recombinant c-Met pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay | ChEMBL. | 25082515 |
IC50 (functional) | = 78.4 uM | Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay | ChEMBL. | 25082515 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.